When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LGVN - Microcap Longeveron soars 177% after Rare Pediatric Disease Designation for candidate
Longeveron Inc.
Microcap stock Longeveron (LGVN +180.3%) is soaring today after announcing that it has received FDA Rare Pediatric Disease Designation for Lomecel-B, its candidate for Hypoplastic Left Heart Syndrome. Average volume for the stock is 121,844. As of 1215p, ~161M shares have traded hands today. Lomecel-B is also in phase 2 to treat aging frailty. The company is also evaluating Lomecel-B for Alzheimer's, where it has completed phase 1.